Research

September 10th, 2020

Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach

September 2nd, 2020

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

August 7th, 2020

The World Brain Death Project: New publication offers significant and unprecedented consensus on the question of when brain death occurs

July 16th, 2020

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

June 25th, 2020

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

June 22nd, 2020

COVID-19 pandemic: Looking back to better tackle future challenges

June 17th, 2020

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

June 11th, 2020

COVID-19 pandemic: the need for privacy and digital contact tracing

Why do some non-smokers get COPD while many heavy smokers don’t?

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Made-in-Canada COVID-19 test developed at McGill receives government support

Subscribe to Research